Stock Institutional Ownership and Shareholders

SecurityXTNT / Xtant Medical Holdings, Inc. (98420P100)
Institutional Owners20
Institutional Shares3,240,969
Outstanding Shares18,169,511 (as of 2017-09-30)
Institutional Value$ 12,189,000 USD

Xtant Medical Holdings, Inc. (AMEX:XTNT) has 20 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,240,969 shares. Largest shareholders include Telemetry Investments, L.L.C., Perkins Capital Management Inc, Orbimed Advisors Llc, Kcg Holdings, Inc., Renaissance Technologies LLC, UBS Group AG, Cambridge Investment Research Advisors, Inc., Vanguard Group Inc, Outfitter Advisors, Ltd., and Northwestern Mutual Wealth Management Co.



Xtant Medical Holdings, Inc. (AMEX:XTNT) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-11-08 13F-HR Texas Yale Capital Corp. 10,000 10,000 0.00 7 7 0.00
2017-10-31 13F-HR PERKINS CAPITAL MANAGEMENT INC 635,104 631,104 -0.63 419 455 8.59
2017-08-11 13F-HR KCG HOLDINGS, INC. 202,349 199,347 -1.48 126 132 4.76
2017-08-03 13F-HR Bank of New York Mellon Corp 10,675 0 -100.00 7 0 -100.00
2017-11-14 13F-HR UBS Group AG 99,111 87,000 -12.22 65 63 -3.08
2017-11-01 13F-HR OUTFITTER ADVISORS, LTD. 121,068 45,805 -62.17 80 33 -58.75
2017-11-14 13F-HR BANK OF AMERICA CORP /DE/ 0 574 0 0
2017-11-17 13F-HR/A-1 Virtu Financial LLC 19,096 14
2017-11-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 27,720 27,720 0.00 19 20 5.26
2017-10-19 13F-HR Winslow, Evans & Crocker, Inc. 15,112 15,112 0.00 9,975 10,896 9.23
2017-11-08 13F-HR D.A. DAVIDSON & CO. 50 0 -100.00 0 0
2017-11-07 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 21,592 41,693 93.09 14 30 114.29
2017-08-09 SC 13G/A Telemetry Investments, L.L.C. 1,416,339 1,416,339 0.00
2017-11-02 13F-HR/A-1 Advisor Group, Inc. 3,760 0 -100.00 2 0 -100.00
2017-11-14 13F-HR BlackRock Inc. 1,455 1,455 0.00 1 1 0.00
2017-11-14 13F-HR MORGAN STANLEY 6,500 9,000 38.46 4 6 50.00
2017-11-14 13F-HR ORBIMED ADVISORS LLC 475,439 475,439 0.00 314 343 9.24
2017-11-14 13F-HR VANGUARD GROUP INC 60,850 59,250 -2.63 41 43 4.88
2017-11-07 13F-HR Cambridge Investment Research Advisors, Inc. 12,800 64,280 402.19 8 46 475.00
2017-11-09 13F-HR FTB Advisors, Inc. 4,000 4,000 0.00 4 3 -25.00
2017-11-13 13F-HR Renaissance Technologies LLC 0 118,792 0 86
2017-11-14 13F-HR ROYAL BANK OF CANADA 1,692 1,692 0.00 1 1 0.00
2017-11-13 13F-HR NORTHERN TRUST CORP 13,271 10

Stock Research Report

Xtant Medical Holdings, Inc. develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Xtant believes the following competitive strengths will be key drivers of future growth of Xtant:

Portfolio of Proprietary Technologies: Xtant has developed a comprehensive portfolio of products that address a broad array of spinal pathologies, anatomies and surgical approaches in the complex spine and minimally invasive surgery (“MIS”) markets. To protect company innovative technologies and techniques, Xtant maintains and continues to grow its intellectual property por...

Click for full article
CUSIP: 98420P100